======= YRDC ======= == Gene Information == * **Official Symbol**: YRDC * **Official Name**: yrdC N6-threonylcarbamoyltransferase domain containing * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79693|79693]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86U90|Q86U90]] * **Interactions**: [[https://thebiogrid.org/search.php?search=YRDC&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20YRDC|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612276|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May regulate the activity of some transporters. {ECO:0000250}. |Sua5 yciO yrdC| |nucleotidyltransferase activity| |regulation of translational fidelity| |tRNA binding| |double-stranded RNA binding| |negative regulation of transport| |mitochondrion| |regulation of transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-3.27| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|-2.59| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-2.47| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-2.47| |[[:results:exp443|SNS-032 15μM R08 exp443]]|-2.29| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-2.22| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-2.22| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|-2.17| |[[:results:exp447|Amiloride 100μM R08 exp447]]|-2.02| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|-1.95| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|-1.93| |[[:results:exp331|A-769662 20μM R07 exp331]]|-1.92| |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|-1.83| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.8| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.78| |[[:results:exp492|iCRT14 30μM R08 exp492]]|-1.76| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-1.76| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.75| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|-1.72| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|-1.72| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|1.72| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.438| Global Fraction of Cell Lines Where Essential: 665/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|27/28| |blood|28/28| |bone|23/26| |breast|32/33| |central nervous system|33/56| |cervix|4/4| |colorectal|16/17| |esophagus|13/13| |fibroblast|0/1| |gastric|16/16| |kidney|20/21| |liver|17/20| |lung|67/75| |lymphocyte|16/16| |ovary|22/26| |pancreas|23/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|0/1| |skin|24/24| |soft tissue|7/9| |thyroid|1/2| |upper aerodigestive|15/22| |urinary tract|25/29| |uterus|4/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1147 * **Expression level (log2 read counts)**: 5.36 {{:chemogenomics:nalm6 dist.png?nolink |}}